Authors:
Rubio-Bueno, P
Villa, E
Carreno, A
Naval, L
Sastre, J
Manzanares, R
Diaz-Gonzalez, FJ
Citation: P. Rubio-bueno et al., Intraoral mandibular distraction osteogenesis: special attention to treatment planning, J CRAN MAX, 29(5), 2001, pp. 254-262
Authors:
Ortega, O
Gallar, P
Carreno, A
Gutierrez, M
Rodriguez, I
Oliet, A
Vigil, A
Gimenez, E
Citation: O. Ortega et al., Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: Influence on blood pressure control, AM J NEPHR, 21(3), 2001, pp. 189-193
Authors:
Gallar, P
Ortega, O
Gutierrez, M
Carreno, A
Dominguez-Gil, B
Hilara, L
Oliet, A
Rodriguez, I
Gimenez, E
Vigil, A
Citation: P. Gallar et al., Automated peritoneal dialysis: impact on residual renal function decline and peritoneal solute permeability, NEFROLOGIA, 21(2), 2001, pp. 200-203
Authors:
Carreno, A
Morales, E
Dominguez-Gil, B
Herrero, JC
Ortiz, M
Gonzalez, E
Praga, M
Citation: A. Carreno et al., The patient with over 100 relapses of minimal change nephrotic syndrome: prolonged complete remission after chlorambucil treatment, NEPH DIAL T, 15(6), 2000, pp. 922-923
Citation: P. Gallar et al., Rate of decline in residual renal function is equal in CAPD and automated peritoneal dialysis patients, PERIT DIA I, 20(6), 2000, pp. 803-805
Authors:
Dominguez-Gil, B
Hernandez, E
Carreno, A
Gonzalez, E
Ortiz, M
Sierra, MP
Rodicio, JL
Praga, M
Citation: B. Dominguez-gil et al., Diagnostic and evolutive characteristics of lupus membranous glomerulonephritis, NEFROLOGIA, 20(6), 2000, pp. 523-531
Citation: A. Carreno et al., Campylobacter fetus fetus: Unknown infection in immunocompromised hemodialysis patients, NEFROLOGIA, 20(4), 2000, pp. 391-392
Authors:
Morales, E
Herrero, JC
Dominguez-Gil, B
Carreno, A
Usera, G
Praga, M
Citation: E. Morales et al., The unusual diabetic patient with advanced renal insufficiency on ACE inhibitors - What is the explanation for her persisting hypokalaemia?, NEPH DIAL T, 14(5), 1999, pp. 1313-1314
Authors:
Morales, JM
Andres, A
Morales, E
Herrero, JC
Cubas, A
Praga, M
Hernandez, E
Ortuno, T
Dominguez-Gil, B
Carreno, A
Delgado, M
Manzanares, C
Citation: Jm. Morales et al., Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubue, Madrid, TRANSPLAN P, 31(7A), 1999, pp. 75S-77S
Authors:
Morales, E
Andres, A
Herrero, JC
Dominguez-Gil, B
Carreno, A
Morales, JM
Hernandez, E
Ortuno, T
Praga, M
Citation: E. Morales et al., Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection, TRANSPLAN P, 31(6), 1999, pp. 2248-2249
Authors:
Herrero, JC
Morales, E
Dominguez-Gil, B
Carreno, A
Cubas, A
Andres, A
Praga, M
Ortuno, T
Hernandez, E
Rodicio, JL
Morales, JM
Citation: Jc. Herrero et al., Mycophenolate mofetil, cyclosporine, and steroids after renal transplantation: Five-year results at a single center, TRANSPLAN P, 31(6), 1999, pp. 2263-2264
Authors:
Cubas, A
Herrero, JC
Morales, E
Carreno, A
Dominguez-Gil, B
Cirujeda, A
Praga, M
Ortuno, T
Hernandez, E
Delgado, M
Andres, A
Morales, JM
Citation: A. Cubas et al., The early impact of mycophenolate mofetil in combination with steroids andcyclosporine neoral after renal transplantation: A six-month analysis, TRANSPLAN P, 31(6), 1999, pp. 2265-2266
Authors:
Herrero, JC
Morales, E
Dominguez-Gil, B
Carreno, A
Usera, G
Aguado, JM
Praga, M
Citation: Jc. Herrero et al., Reactivation of multisystemic sarcoidosis after immunosuppression withdrawal in a transplanted patient returning to chronic dialysis, NEPH DIAL T, 13(12), 1998, pp. 3280-3281